A Phase IV, 6-Week, Randomised, Double-Blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK [United Kingdom] Asian Subjects With Primary Hypercholesterolaemia.
Phase of Trial: Phase IV
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Atorvastatin; Rosuvastatin
- Indications Hypercholesterolaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Acronyms SHUKRA
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 30 Mar 2010 Actual patient number (55) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Status changed from in progress to discontinued as reported by ClinicalTrials.gov.